Expert consensus on the use of glucocorticoid aerosol inhalation therapy in pediatrics (revised 2018)
Guide name: Expert consensus on the use of glucocorticoid aerosol inhalation therapy in pediatrics (revised 2018)
Issued by: China pediatric related medical expert group (collectively)
Post date: February 20, 2018
Inhaled corticosteroids (ICS) are commonly used to treat acute and chronic airway inflammation.ICS different dosage forms of drugs, such as pressure quantitative aerosol, dry powder and liquid atomization inhalation suspension, shows good curative effect in clinical application, the atomizing inhaled corticosteroids, with its reliable curative effect, good safety and operability, pediatric clinical won a wide application in our country, especially in young children, including all levels of medical institutions and family; It is not only used for the long-term control and acute attack of bronchial asthma, but also for other respiratory diseases.
The editorial department of the journal of clinical pediatrics organized pediatric respiratory experts to revise the consensus again, in order to guide pediatric medical workers and families to correctly choose and use inhaled glucocorticoids, so as to standardize and improve the application of inhaled glucocorticoids in pediatric clinical practice. This consensus is formulated in accordance with the basic principles of evidence-based medicine, referring to the latest research data and relevant guidelines at home and abroad.
Classification: respiratory, pediatric